Long term effects of aminoguanidine on insulin release and biosynthesis: Evidence that the formation of advanced glycosylation end products inhibits B cell function

Endocrinology

Volumn 138, Issue 1, 1997, Pages 273-280

  Tajiri, Yuji ^b   Möller, Christer ^b   Grill, Valdemar ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; GLYCOSYLATED PROTEIN; INSULIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; INSULIN RELEASE; INSULIN SYNTHESIS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN SYNTHESIS; RAT; RNA ANALYSIS;

EID: 0031025828     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.1.4851     Document Type: Article

References (33)

1. Weir GC, Leahy JL, Bonner-Weir S 1986 Experimental reduction of β-cell mass: implications for the pathogenesis of diabetes. Diabetes Metab Rev 2:125-161
2. Leahy JL, Cooper HE, Deal DA, Weir GC 1986 Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion: a study in normal rats using chronic in vivo glucose infusions. J Clin Invest 77:908-915
3. Palmer JP, Benson JW, Walter RM, Ensinck JW 1976 Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects. J Clin Invest 58:565-570
4. Leahy JL 1990 Natural history of β-cell dysfunction in NIDDM. Diabetes Care 13:992-1010
5. Sako Y, Grill V 1990 A 48 h lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B-cell oxidation through a process likely coupled to fatty acid oxidation. Endocrinology 127:1580-1589
6. Sako Y, Grill V 1990 Coupling of β-cell desensitization by hyperglycaemia to excessive stimulation and circulating insulin in glucose-infused rats. Diabetes 39:1580-1583
7. Brownlee M, Cerami A, Vlassara H 1988 Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1321
8. Brownlee M, Vlassara H, Kooney T, Ulrich P, Cerami A 1986 Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232:1629-1632
9. Brownlee M 1994 Glycation and diabetic complications. Diabetes 43:836-841
10. Hammes H-P, Martin S, Federlin K, Geisen K, Brownlee M 1991 Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci USA 88:11555-11558
11. Soules-Liparota T, Cooper M, Papazoglou D, Clarke B, Jerums G 1991 Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozotocin-induced diabetic rat. Diabetes 40:1328-1335
12. Cameron NE, Cotter MA, Dines K, Love A 1992 Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats. Diabetologia 35:946-950
13. Kihara M, Schmelzer JD, Poduslo JF, Curran GL, Nickander KK, Low PA 1991 Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology and oxygen free radicals. Proc Natl Acad Sci USA 88:6107-6111
14. Zähner D, Malaisse WJ 1992 Effects of advanced glycation products and aminoguanidine upon insulin release. Diabetes Nutr Metab 5:43-46
15. Edelstein D, Brownlee M 1992 Mechanistic studies of advanced glycation end product inhibition by aminoguanidine. Diabetes 41:26-29
16. Fu MX, Wells-Knecht KJ, Blackledge JA, Lyons TJ, Thorpe SR, Baynes JW 1994 Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanism, and inhibition of late stages of the Maillard reaction. Diabetes 43:676-683
17. Tasaka Y, Nakaya F, Matsumoto H, Omori Y 1994 Effects of aminoguanidine on insulin release from pancreatic islets. Endocr J 41:309-313
18. Corbett JA, Tilton RG, Chang K, Hasan KS, Ido Y, Wang JL, Sweetland MA, Lancaster Jr JR, Williamson JR, McDaniel ML 1992 Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction Diabetes 41:552-556
19. Tilton RG, Chang K, Hasan KS, Smith SR, Perrash JM, Misko TP, Moore WM, Currie MG, Corbett JA, McDaniel ML, Williamson JR 1993 Prevention of diabetic vascular dysfunction by guanidines-inhibition of nitric oxide synthase vs. advanced glycation end-product formation. Diabetes 42:221-232
20. Lacy PE, Kostianovsky M 1967 Method for the isolation of intact islets of Langerhans from the pancreas. Diabetes 16:35-39
21. Monnier VM, Kohn RH, Cerami A 1984 Accelerated age-related browning of human collagen in diabetes mellitus. Proc Natl Acad Sci USA 81:583-587
22. Östenson C-G, Grill V 1987 Evidence that hyperglycemia increases muscarinic binding in pancreatic islets of the rat. Endocrinology 121:1705-1710
23. Umbreit WW, Burris RH, Stauffer JF 1957 Manometric Techniques. Burgess, Minneapolis, pp 149-150
24. Halban PA, Wollheim CB, Blondel B, Renold AE 1980 Long-term exposure of isolated pancreatic islets to mannoheptulose: evidence for insulin degradation in the β-cell. Biochem Pharmacol 29:2625-2633
25. Chomczynski P, Nicoletta S 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chlorform extraction. Anal Biochem 162:156-159
26. Möller C, Arner P, Sonnenfeld T, Norstedt G 1991 Quantitative comparison of insulin-like growth factor mRNA levels in human and rat tissues analysed by solution hybridization assay. J Mol Endocrinol 7:213-222
27. Herbert V, Lau KS, Gottlieb CW, Bleicher SJ 1965 Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25:1375-1384
28. Grill V, Rundfeldt M, Efendic S 1981 Previous exposure to glucose enhances somatostatin secretion from the isolated perfused rat pancreas. Diabetologia 30:495-500
29. Dionne KE, Colton CK, Yarmush ML 1993 Effect of hypoxia on insulin secretin by isolated rat and canine islets of Langerhans. Diabetes 42:12-21
30. Olson LK, Redmon JB, Towle HC, Robertson RP 1993 Chronic exposure of HIT cells to high glucose concentrations paradoxically decreases insulin gene transcription and alters binding of insulin gene regulatory protein. J Clin Invest 92:514-519
31. Robertson PR, Olson KL, Zhang H-J 1994 Differentiating glucose toxicity from glucose desensitization: a novel message from the insulin gene. Diabetes 43:1085-1089
32. UK Prospective Diabetes Study Group 1995 U.K. prospective diabetes study 16. Overview of 6 year's therapy of type II diabetes: a progressive disease. Diabetes 44:1249-1258
33. Inoue K, Norgren S, Luthman H, Grill V, Chronic hyperglycemia induces defects in B-cell functioning which are ameliorated by aminoguanidine. 15th IDF Congress, Kobe, Japan, 1994 (Abstract 105)